PDF(Pubmed)
Abstract：
UNASSIGNED: Cow\'s milk protein allergy (CMPA) affects 2%-7% of infants and is managed with hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including contamination led to specialty formula shortages, highlighting CMPA management challenges. Understanding healthcare providers\' (HCPs) decision-making in transitioning to alternative formulas during shortages is crucial. Limited attention has been given to how pediatric physicians make these choices.
UNASSIGNED: This study utilized US HCPs\' de-identified survey data to assess driving factors when switching extensively hydrolyzed formulas during shortages.
UNASSIGNED: 104 eligible HCPs participated, including general pediatrics, pediatric allergy/immunology, and pediatric gastroenterology specialists. Safety, tolerability, and efficacy were identified as top factors for switching formulas. Formula 1 was considered well-tolerated, patient-accepted, and safe by all HCPs. Most expressed strong belief in Formula 1\'s safety and effectiveness.
UNASSIGNED: Findings inform CMPA management during shortages, offering guidance to HCPs for suitable formula selection and enhanced infant care.
UNASSIGNED: This study utilized US HCPs\' de-identified survey data to assess driving factors when switching extensively hydrolyzed formulas during shortages.
UNASSIGNED: 104 eligible HCPs participated, including general pediatrics, pediatric allergy/immunology, and pediatric gastroenterology specialists. Safety, tolerability, and efficacy were identified as top factors for switching formulas. Formula 1 was considered well-tolerated, patient-accepted, and safe by all HCPs. Most expressed strong belief in Formula 1\'s safety and effectiveness.
UNASSIGNED: Findings inform CMPA management during shortages, offering guidance to HCPs for suitable formula selection and enhanced infant care.
摘要：
■奶牛的牛奶蛋白过敏（CMPA）影响2％-7％的婴儿，并采用低过敏性配方进行管理。2022年召回婴儿配方奶粉，原因包括污染导致特殊配方奶粉短缺，强调CMPA管理挑战。了解医疗保健提供者（HCP）在短缺期间过渡到替代方案的决策至关重要。对儿科医师如何做出这些选择的关注有限。
■本研究利用美国HCP去识别调查数据来评估在短缺期间转换广泛水解配方时的驱动因素。
■104个合格的HCP参加了，包括普通儿科，儿科过敏/免疫学，和儿科胃肠病专家。安全,耐受性,疗效被确定为转换配方的首要因素。公式1被认为是耐受性良好的，患者接受，所有HCP都是安全的。大多数人对F1的安全性和有效性表示了强烈的信念。
■发现在短缺期间通知CMPA管理层，为HCP选择合适的配方和加强婴儿护理提供指导。
■本研究利用美国HCP去识别调查数据来评估在短缺期间转换广泛水解配方时的驱动因素。
■104个合格的HCP参加了，包括普通儿科，儿科过敏/免疫学，和儿科胃肠病专家。安全,耐受性,疗效被确定为转换配方的首要因素。公式1被认为是耐受性良好的，患者接受，所有HCP都是安全的。大多数人对F1的安全性和有效性表示了强烈的信念。
■发现在短缺期间通知CMPA管理层，为HCP选择合适的配方和加强婴儿护理提供指导。
